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Abstract: We aimed to analyze trends in hospital admissions due to adverse drug effects between 
the years 2000 to 2007 among the elderly using the National Inpatient Sample (NIS) of the Health-
care Cost and Utilization Project. We identified the discharges with the principal and all listed 
diagnoses related to adverse drug effects and associated hospital charges using the International 
Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9) codes. Between 2000 
and 2007, 321,057 patients over 65 years were discharged with a principal diagnosis related to 
an adverse drug effect. Hospital charges were $5,329,276,300 or $666,159,537 annual cost. The 
number of discharges and total hospital charges did not change over the examined years, while 
mean charge per discharge increased on average by $1064 ± 384 per year. Total hospital charges 
for drug-induced gastritis with hemorrhage increased the most by $11,206,555 per year among 
those 66–84 years old and by $8,646,456 per year among those older than 85 years. During 
2007, 791,931 elderly had adverse treatment effects among all listed diagnoses with hospital 
charges of $937,795,690. Effective drug management interventions are needed to improve 
safety of treatments in the elderly.
Keywords: adverse drug reaction reporting systems, aged, hospitalization, international 
  classification of diseases
Introduction
Adverse drug events result in hospital admissions, increased costs, and poor quality of 
health care.1 Prevention of adverse treatment effects is essential for improving patient 
safety and quality of care.2 With $2.5 trillion in annual spending for healthcare in the 
US, adverse treatment effects contribute to unnecessary and preventable cost.2 Hospital 
admissions due to adverse drug effects can be prevented with high quality care.3 Aging 
patients are most vulnerable to multimorbid conditions and polypharmacy.4 However, 
hospital admissions for adverse drug events among elderly have not been evaluated 
in relation to quality of care. We aimed to examine frequency and hospital charges of 
adverse treatment effects among elderly using the National Inpatient Sample (NIS) 
of the Healthcare Cost and Utilization Project.5
Methods
We analyzed total number of discharges with a principal diagnosis of adverse drug 
events in 2000–2007. We defined elderly inpatients in two age categories: 65–84 and 
85 years of age. Principal diagnoses as the reasons for admission were identified 
using codes of the International Classification of Diseases, ninth Revision, Clinical 
Modification (ICD-9-CM), see Appendix Table 1).6,7 We defined adverse drug effects as Clinical Pharmacology: Advances and Applications 2010:2 42
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Table 1 Total number of discharges with iCD-9-CM principal diagnosis of adverse drug effects in elderly in the US in 2000–2007*
ICD-9-CM Principal diagnosis Discharges Total cost ($)
535.40 Specified gastritis without mention of hemorrhage 57786 860,998,714
535.41 Specified gastritis with hemorrhage 87807 1,572,983,700
962.3 Poisoning by insulins and antidiabetic agents, acetohexamide, biguanide derivatives, 
oral, chlorpropamide, glucagon, insulin, phenformin
15319 188,311,752
962.7 Poisoning by thyroid and thyroid derivatives, dextrothyroxin, levothyroxine  
sodium, liothyronine, thyroglobulin
255 2,413,273
963.0 Poisoning by antiallergic and antiemetic drugs, antihistamines, chlorpheniramine,  
diphenhydramine, diphenylpyraline, thonzylamine, tripelennamine
803 8,633,615
963.1 Poisoning by antineoplastic and immunosuppressive drugs, azathioprine, busulfan, 
chlorambucil, cyclophosphamide, cytarabine, fluorouracil
209 4,110,450
964.2 Poisoning by anticoagulants, coumarin, heparin, phenindione, warfarin sodium 12358 177,192,573
965.00 Poisoning by opium (alkaloids), unspecified 2888 56,110,222
965.02 Poisoning by methadone 1323 26,343,332
965.09 Poisoning by opiates and related narcotics other, meperidine (pethidine), morphine 12583 217,660,115
965.1 Poisoning by salicylates, acetylsalicylic acid (aspirin), salicylic acid salts 2950 49,525,273
965.4 Poisoning by aromatic analgesics, not elsewhere classified, acetanilid,  
paracetamol (acetaminophen), phenacetin (acetophenetidin)
5469 109,796,708
965.61 Poisoning by propionic acid derivatives, fenoprofen, flurbiprofen, 
ibuprofen, ketoprofen, naproxen, oxaprozin
229 2,148,674
965.8 Poisoning by other specified analgesics and antipyretics, pentazocine 3443 59,098,750
965.9 Poisoning by unspecified analgesic and antipyretic 586 6,430,193
966.1 Poisoning by hydantoin derivatives, phenytoin 3778 47,403,049
966.3 Poisoning by other and unspecified anticonvulsants 1969 22,563,220
966.4 Poisoning by anti-Parkinsonism drugs, amantadine, ethopropazine  
(profenamine), levodopa (L-dopa)
522 4,671,189
967.0 Poisoning by barbiturates, amobarbital (amylobarbitone), barbital (barbitone),  
butabarbital (butabarbitone), pentobarbital (pentobarbitone), phenobarbital 
(phenobarbitone)
870 14,641,286
967.8 Poisoning by other sedatives and hypnotics 6162 87,972,831
967.9 Poisoning by unspecified sedative or hypnotic, sleeping, drug  
nOS, pill nOS, tablet nOS
2191 33,068,947
968.0 Poisoning by central nervous system muscle-tone depressants,  
chlorphenesin (carbamate), mephenesin, methocarbamol
552 5,517,789
968.5 Poisoning by surface (topical) and infiltration anesthetics, cocaine,  
lidocaine (lignocaine), procaine, tetracaine
78 946,598
969.0 Poisoning by antidepressants, amitriptyline, imipramine, monoamine  
oxidase (MAO) inhibitors
5962 93,815,748
969.1 Poisoning by phenothiazine-based tranquilizers, chlorpromazine, 
fluphenazine, prochlorperazine, promazine
53 235,756
969.3 Poisoning by other antipsychotics, neuroleptics, and major tranquilizers 1482 22,016,443
969.4 Poisoning by benzodiazepine-based tranquilizers, chlordiazepoxide,  
diazepam, flurazepam, lorazepam, medazepam, nitrazepam
19446 328,528,129
969.5 Poisoning by other tranquilizers, hydroxyzine, meprobamate 301 1,910,136
969.8 Poisoning by other specified psychotropic agents 1511 22,890,849
970.8 Poisoning by other specified central nervous system stimulants 660 12,158,791
971.3 Poisoning by sympatholytics (antiadrenergics), phenoxybenzamine,  
tolazoline hydrochloride
864 10,867,698
972.0 Poisoning by cardiac rhythm regulators, practolol, procainamide,  
propranolol, quinidine
1250 14,339,989
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Table 1 (Continued )
ICD-9-CM Principal diagnosis Discharges Total cost ($)
972.1 Poisoning by cardiotonic glycosides and drugs of similar action, digitalis  
glycosides, digoxin, strophanthins
8534 119,955,030
972.4 Poisoning by coronary vasodilators, dipyridamole, nitrates (nitroglycerin), nitrites 2313 33,649,395
972.6 Poisoning by other antihypertensive agents, guanethidine,  
rauwolfia alkaloids, reserpine
5705 69,053,555
972.9 Poisoning by other and unspecified agents primarily affecting  
the cardiovascular system
2138 27,653,973
974.3 Poisoning by saluretics, benzothiadiazides, chlorothiazide group 96 1,484,756
974.4 Poisoning by other diuretics, ethacrynic acid, furosemide 1922 18,037,222
975.2 Poisoning by skeletal muscle relaxants 269 3,640,433
977.8 Poisoning by other specified drugs and medicinal substances,  
diagnostic agents and kits
3825 54,184,255
Total All diagnoses 321,057 5,329,276,300
Notes: *hCUPnet, healthcare Cost and Utilization Project. Agency for healthcare research and Quality, rockville, MD. (http://hcupnet.ahrq.gov/)
Abbreviation: NOS, not otherwise specified.
poisoning due to inappropriate uses or medication errors (eg, 
wrong medication, wrong patient, overdose) and as an adverse 
drug reaction.8 We did not analyze clinical side effects includ-
ing drug-induced psychoses (ICD codes 10 292.0–292.9) or 
dermatitis (ICD codes 5 692.3, 692.9, 693.0, 693.8, 693.9).8 
We identified all listed diagnoses of adverse treatment effects 
that coexisted at the time of admission, or that developed 
  during the stay in 2007 using ICD-9-CM codes6 (Appendix 
Table 2). We analyzed mean hospital charges5 as the amount 
the hospital charged for the entire hospital stay for each ICD 
code. We multiplied the number of discharges by the mean 
hospital charge to calculate total hospital charges for each ICD 
code for each year and for the total time period from 2000 
to 2007. We analyzed time trend in discharges and hospital 
charges with years as a continuous variable. We used restricted 
maximum likelihood (REML) estimation methods and -2 Res 
Log Likelihood Fit Statistics with mixed procedure9 in SAS. 
All calculations were performed at 95% confidence levels 
using a two-sided P value with SAS software.10
Results
During the period between 2000 and 2007, 321,057 hospital 
admissions among the elderly had principal diagnoses of 
adverse drug effects (Table 1). Total hospital charges were 
$5,329,276,300 or $666,159,537 per year.
Drug-induced gastritis with hemorrhage (87,807 
discharges) and without mention of hemorrhage (57,786 dis-
charges) constituted 31% and 21% of all drug-induced hospi-
talizations, respectively. Poisoning by benzodiazepine-based 
tranquilizers, insulins, antidiabetic agents, and anticoagulants 
contributed to 5% or more of drug-induced hospitalizations 
in the elderly.
Hospital charges for gastritis with hemorrhage 
($1,572,983,700 or 36% of all hospital charges), gastritis 
without mention of hemorrhage ($860,998,714 or 20% of 
all hospital charges), for poisoning by benzodiazepine-based 
tranquilizers ($328,528,129 or 8% of all hospital charges), 
and for poisoning by opiates ($217,660,115 or 5% of all 
hospital charges) were the largest drug-induced charges 
among elderly patients.
Total number of hospital admissions due to adverse 
drug effects increased from 36,199 in 2000 to 42,057 in 
2007 (Figure 1). Total hospital charges increased from 
$393,618,776 in 2000 to $905,776,719 in 2007 (Figure 2).
Elderly patients constituted more than 50% of all 
admissions due to poisoning by anticoagulants and car-
diotonics. Half of all hospital admissions with a principal 
diagnosis of poisoning by an anti-Parkinsonism drug 
or drug-induced gastritis with hemorrhage occurred in 
elderly patients.
The number of discharges and total hospital charges did 
not change over the examined years (P values for trend 0.61 
and 0.11, respectively) while the mean charge per discharge 
increased on average by $1064 ± 384 per year (P value for 
trend 0.006).
Hospital admissions due to drug-induced gastritis and 
due to poisoning by glycosides decreased during 2000–2007 
(Table 2). Hospital admissions due to poisoning by opiates Clinical Pharmacology: Advances and Applications 2010:2 44
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or insulin and antidiabetic agents increased in the examined 
time period (Table 2).
Mean hospital charges increased significantly for 
poisoning by methadone and salicylates. Hospital charges 
in elderly who were hospitalized for drug-induced gastri-
tis with hemorrhage increased by $19,853,011 per year. 
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Figure 1 Trend in total number of elderly discharged with iCD-9-CM principal diagnosis of adverse drug effect in the US for 2000–2007.*
*hCUPnet, healthcare Cost and Utilization Project.   Agency for healthcare research and Quality, rockville, MD. (http://hcupnet.ahrq.gov/)
Hospital charges for patients aged 65–84 who were hospital-
ized for insulin poisoning and antidiabetic agents increased 
by $4,600,443 per year (Table 2).
All listed diagnoses related to adverse treatment effects 
in elderly in 2007 constituted 791,931 discharges and 
$937,795,690 hospital charges (Table 3). Adverse effects 
Figure 2 Trend in total cost for discharged elderly with a iCD-9-CM principal diagnosis of adverse drug effects in the US for 2000–2007.*
*hCUPnet, healthcare Cost and Utilization Project.   Agency for healthcare research and Quality, rockville, MD. (http://hcupnet.ahrq.gov/)
$1,000,000,000.00
$900,000,000.00
$800,000,000.00
$700,000,000.00
$600,000,000.00
$500,000,000.00
$400,000,000.00
$300,000,000.00
$200,000,000.00
$100,000,000.00
$0.00
2000
total cost Poly. (total cost)
2001 2002 2003 2004 2005
R2 = 0.9922
2006 2007Clinical Pharmacology: Advances and Applications 2010:2 45
Adverse drug effects in hospitalized elderly Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
Table 2 Signficant time trend in discharges with a ICD-9-CM principal diagnosis of adverse drug effects in elderly in the US in 2000–2007*
Code  Age  Change per year  Lower 95% CI  Upper  
95% CI
Total number of discharges        
Poisoning by opiates and related narcotics other, meperidine  
(pethidine), morphine
65–84
85+
131
109
55
38
207
181
Specified gastritis with hemorrhage 85+ -91 -162 -20
Specified gastritis without mention of hemorrhage 85+ -89 -161 -18
Poisoning by cardiotonic glycosides and drugs of similar action,  
digitalis glycosides, digoxin, strophanthins
85+ -86 -157 -15
Poisoning by insulins and antidiabetic agents, acetohexamide,  
biguanide derivatives, oral, chlorpropamide, glucagon,  
insulin, phenformin
65–84 88 12 164
Mean hospital charges, $        
Poisoning by methadone 65–84 $1,583 $465 $2,701
Poisoning by salicylates, acetylsalicylic acid (aspirin),  
salicylic acid salts
65–84
85+
$1,229
$1,006
$225
$63
$2,233
$1,948
Poisoning by opium (alkaloids), unspecified 65–84 $1,291 $36 $2,546
Total hospital charges, $        
Specified gastritis without mention of hemorrhage 65–84
85+
$7,646,061
$5,105,871
$5,589,408
$3,183,223
$9,702,715
$7,028,519
Specified gastritis with hemorrhage 65–84
85+
$11,206,555
$8,646,456
$9,149,902
$6,723,808
$13,263,209
$10,569,104
Poisoning by insulins and antidiabetic agents, acetohexamide,  
biguanide derivatives, oral, chlorpropamide, glucagon,  
insulin, phenformin
65–84 $4,600,443 $2,543,790 $6,657,096
Poisoning by opiates and related narcotics other,  
meperidine (pethidine), morphine
65–84
85+
$6,502,314
$3,990,380
$4,422,840
$2,035,223
$8,581,789
$5,945,538
Poisoning by benzodiazepine-based tranquilizers, chlordiazepoxide,  
diazepam, flurazepam, lorazepam, medazepam, nitrazepam
65–84 $5,551,531 $3,494,877 $7,608,184
Poisoning by medicinal agents, not specified 65–84 $2,498,657 $1,910,589 $3,086,724
Poisoning by other sedatives and hypnotics 65–84 $3,890,757 $1,834,103 $5,947,410
Poisoning by aromatic analgesics, not elsewhere classified,  
acetanilid, paracetamol (acetaminophen), phenacetin (acetophenetidin)
65–84 $3,912,772 $1,807,026 $6,018,518
Poisoning by anticoagulants, coumarin, heparin, phenindione,  
warfarin sodium
65–84 $3,564,249 $1,507,595 $5,620,902
Poisoning by other antihypertensive agents, guanethidine,  
rauwolfia alkaloids, reserpine
65–84 $3,354,306 $1,297,653 $5,410,959
Poisoning by benzodiazepine-based tranquilizers,  
chlordiazepoxide, diazepam, flurazepam, lorazepam,  
medazepam, nitrazepam
85+ $3,035,785 $1,113,137 $4,958,433
Poisoning by opium (alkaloids), unspecified 65–84 $4,019,466 $1,430,863 $6,608,070
Poisoning by unspecified sedative or hypnotic,  
sleeping drug nOS, pill nOS, tablet nOS
65–84 $2,824,729 $680,482 $4,968,976
Poisoning by salicylates, acetylsalicylic acid (aspirin),  
salicylic acid salts
65–84 $2,619,376 $547,870 $4,690,883
Poisoning by other specified analgesics and  
antipyretics, pentazocine
65–84 $2,753,695 $553,314 $4,954,075
Poisoning by antidepressants, amitriptyline, imipramine,  
monoamine oxidase (MAO) inhibitors
65–84 $2,649,658 $522,619 $4,776,698
Poisoning by hydantoin derivatives, phenytoin 65–84 $2,531,952 $465,643 $4,598,262
Poisoning by other specified drugs and medicinal substances,  
diagnostic agents and kits
65–84 $2,632,369 $473,890 $4,790,848
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Table 2 (Continued )
Code  Age  Change per year  Lower 95% CI  Upper 
95% CI
Poisoning by other diuretics, ethacrynic acid, furosemide 65–84 $2,604,287 $432,360 $4,776,214
Poisoning by other and unspecified agents primarily  
affecting the cardiovascular system
65–84 $2,615,983 $426,308 $4,805,659
Poisoning by cardiotonic glycosides and drugs of  
similar action, digitalis glycosides, digoxin, strophanthins
65–84 $2,372,342 $315,689 $4,428,996
Poisoning by insulins and antidiabetic agents, acetohexamide, biguanide 
derivatives, oral, chlorpropamide, glucagon, insulin, phenformin
85+ $2,093,655 $171,007 $4,016,303
Poisoning by coronary vasodilators, dipyridamole, nitrates 
(nitroglycerin), nitrites
65–84  $2,282,972  $177,226  $4,388,718 
Abbreviation: NOS, not otherwise specified.
*hCUPnet, healthcare Cost and Utilization Project.   Agency for healthcare research and Quality, rockville, MD. (http://hcupnet.ahrq.gov/)
of anticoagulants were experienced by 94,793 patients 
65–84 years (55.65% of all discharged with this diagno-
sis) and 31,807 inpatients older than 85 years (19% of all 
discharged with this diagnosis). Total hospital charges for 
adverse effects of anticoagulants in 2007 in elderly were 
$404,165,145 and $47,642,222 in the two age categories, 
respectively. Adverse effects of diuretics in 2007 afflicted 
29,655 elderly patients, with total hospital charges of 
$46,906,127. Adverse effects of corticosteroids afflicted 
87,454 adults 65–84 years of age (41% of all discharged with 
this diagnosis) with a total hospital charge of $317,339,123. 
Much less expected was a large number of elderly with 
unspecified adverse drug effects. In 2007, 27,976 elderly 
experienced adverse drug effects with unknown definitive 
cause. Total hospital charges for such unspecified adverse 
drug effects were $35,520,572.
Discussion
Hospital admissions due to adverse drug effects are common. 
While the rate of admissions remained the same during the 
study period, costs continued to increase. Several pharma-
cologic groups including antidiabetic drugs, anticoagulants, 
cardiotonics, saluretics, and anti-inflammatory medications 
are responsible for the most common adverse events in the 
elderly. Hospital charges are substantial when all listed 
diagnoses related to adverse drug effects in the elderly are 
analyzed.
We did not analyze probable variability of adverse drug 
effects among geographical regions, types of hospitals, or 
patient income. Such variability may be associated with 
differences in hospital admission and charges but does not 
decrease the significance of the problem of very common 
and costly adverse drug events in the elderly. We could not 
judge the validity of hospital discharge codes in identifying 
drug-specific adverse effects.11 Previous studies have dem-
onstrated poor predictive value of hospital discharge codes 
in identifying drug adverse effects.11,12
Hospital admissions due to adverse drug effects may 
reflect inadequate drug management in outpatient settings 
that cannot be analyzed using the National Inpatient Sample. 
Outpatient clinical pharmacology services may reduce adverse 
drug events in elderly,13–15 but preventive effects on hospital 
admissions are not clear. Effective drug management interven-
tions are needed to improve safety of treatments in elderly.
Table 3 hospitalization with iCD9-CM all-listed diagnosis codes of adverse treatment effects in elderly, 2007*
Principal diagnosis  Year of age  Total number  
of discharges
% of all discharges  
with ICD code
Charges, $ 
(mean)
Total cost 
Accidental poisoning by methadone 65–84 271 6.30% 37 10,063
Accidental poisoning by other opiates and related 
narcotics, morphine, opium (alkaloids)
65–84
85+
3,984
546
21.80
2.99
196
56
781,447
30,546
Accidental poisoning by salicylates, acetylsalicylic 
acid (aspirin), salicylic acid salts, amino  
derivatives of salicylic acid
65–84
85+
248
80
13.72
4.43
37
21
9,149
1,698
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Table 3 (Continued )
Principal diagnosis  Year of age  Total number  
of discharges
% of all discharges  
with ICD code
Charges, $ 
(mean)
Total cost 
Accidental poisoning by aromatic analgesics,  
not elsewhere classified, acetanilid, paracetamol  
(acetaminophen), phenacetin (acetophenetidin)
65–84
85+
631
78
8.67
1.08
60
20
38,183
1,531
Accidental poisoning by antirheumatics  
(antiphlogistics), gold salts, indomethacin,
65–84 93 10.08 22 1,998
Accidental poisoning by other specified  
analgesics and antipyretics, pentazocine
65–84
85+
747
148
26.65
5.27
62
28
46,351
4,109
Accidental poisoning by unspecified analgesic  
or antipyretic
65–84 127 25.19 25 3,185
Accidental poisoning by barbiturates 65–84 117 11.22 24 2,821
Accidental poisoning by other specified sedatives  
and hypnotics
65–84
85+
810
174
25.87
5.55
69
31
55,549
5,316
Accidental poisoning by unspecified sedative or  
hypnotic, sleeping drug nOS, pill nOS, tablet nOS
65–84
85+
853
121
27.79
3.94
70
26
59,915
3,103
Accidental poisoning by benzodiazepine-based  
tranquilizers, chlordiazepoxide, diazepam,  
flurazepam, lorazepam, medazepam, nitrazepam
65–84
85+
2,378
336
15.08
2.13
123
40
293,373
13,516
Accidental poisoning by other specified  
tranquilizers, hydroxyzine, meprobamate
65–84
85+
308
68
8.91
1.96
42
19
12,890
1,253
Accidental poisoning by antidepressants,  
amitriptyline, imipramine, monoamine oxidase  
(MAO) inhibitors
65–84
85+
542
113
11.61
2.42
55
23
29,870
2,639
Accidental poisoning by psychostimulants,  
amphetamine, caffeine
65–84 58 2.21 17 992
Accidental poisoning by central nervous system  
stimulants, analeptics, opiate antagonists
65–84 307 2.75 54 16,439
Accidental poisoning by other  
psychotropic agents
65–84 145 17.50 30 4,278
Accidental poisoning by anticonvulsant and  
anti-Parkinsonism drugs, amantadine, hydantoin 
  derivatives, oxazolidine derivatives  
(paramethadione, trimethadione)
65–84
85+
998
216
20.90
4.52
84
33
83,967
7,043
Accidental poisoning by other central  
nervous system depressants, ether, gaseous  
anesthetics, halogenated hydrocarbon derivatives, 
intravenous anesthetics, thiobarbiturates
65–84 188 6.59 33 6,120
Accidental poisoning by parasympathomimetics  
(cholinergics), acetylcholine, pilocarpine,  
anticholinesterase: organophosphorus, reversible
65–84 94 60.57 22 2,067
Accidental poisoning by sympatholytics  
(antiadrenergics), phenoxybenzamine,  
tolazoline hydrochloride
65–84
85+
250
70
45.94
12.95
37
19
9,184
1,317
Accidental poisoning by antibiotics 65–84 158 28.60 28 4,458
Accidental poisoning by other anti-infectives 65–84 79 28.19 20 1,557
Accidental poisoning by hormones and synthetic 
substitutes
65–84
85+
2,748
677
39.98
9.86
171
70
468,595
47,416
Accidental poisoning by primarily systemic agents 65–84 403 18.92 52 20,871
Accidental poisoning by agents primarily 
 affecting blood constituents
65–84
85+
1,656
509
49.74
15.28
110
56
182,285
28,301
Accidental poisoning by agents primarily affecting 
cardiovascular system
65–84
85+
65–84
2,658
874
203
41.14
13.52
35.52
139
76
33
370,247
66,654
6,784
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Table 3 (Continued )
Principal diagnosis  Year of age  Total number  
of discharges
% of all discharges  
with ICD code
Charges, $ 
(mean)
Total cost 
Accidental poisoning by agents primarily affecting 
gastrointestinal system
85+ 63 10.94 17 1,086
Accidental poisoning by water, mineral,  
and uric acid metabolism drugs
65–84
85+
841
246
44.72
13.08
70
37
59,154
9,144
Accidental poisoning by agents primarily acting  
on the smooth and skeletal muscles and  
respiratory system
65–84 348 16.68 45 15,792
Accidental poisoning by agents primarily  
affecting skin and mucous membrane,  
ophthalmologic, otorhinolaryngologic,  
and dental drugs
65–84 86 21.86 24 2,013
Accidental poisoning by other 
specified drugs, central appetite depressants
65–84
85+
566
152
20.85
5.61
59
26
33,256
4,033
Accidental poisoning by unspecified drug 65–84
85+
697
131
25.78
4.84
66
26
46,298
3,377
Accidental cut, puncture, perforation, or  
hemorrhage during surgical operation
65–84
85+
11,833
1,318
33.28
3.71
890
111
10,531,148
146,408
Accidental cut, puncture, perforation, or  
hemorrhage during endoscopic examination
65–84
85+
1,551
354
49.30
11.24
132
46
203,951
16,191
Accidental cut, puncture, perforation, or  
hemorrhage during aspiration of fluid or 
tissue, puncture, and catheterization, abdominal  
paracentesis, aspirating needle biopsy,  
blood sampling
65–84 334 45.94 57 18,917
Accidental cut, puncture, perforation, or  
hemorrhage during heart catheterization
65–84
85+
830
103
51.78
6.41
111
25
92,489
2,555
Accidental cut, puncture, perforation, or  
hemorrhage during other  
specified medical care
65–84
85+
2,840
602
39.14
8.30
238
65
675,262
39,207
Accidental cut, puncture, perforation, or hemorrhage 
during unspecified medical care
65–84 155 30.32 39 6,053
Foreign object left in body during  
surgical operation
65–84 268 30.35 38 10,139
Foreign object left in body during other specified 
procedures
65–84 102 29.11 23 2,378
Mechanical failure of instrument or apparatus  
during surgical operation
65–84 93 34.75 23 2,145
Mechanical failure of instrument or apparatus  
during other specified procedures
65–84 59 34.92 17 1,037
Other specified misadventures during  
medical care, performance of inappropriate  
treatment
65–84
85+
1,845
348
42.30
7.99
184
54
340,133
18,783
Unspecified misadventure during medical care 65–84
85+
439
98
36.56
8.17
84
27
36,855
2,624
Causing adverse effects, penicillins, natural,  
synthetic, semisynthetic, such as ampicillin,  
cloxacillin, nafcillin, oxacillin
65–84
85+
4,670
1,316
30.60
8.62
252
104
1,175,580
136,598
Causing adverse effects, antifungal antibiotics 65–84
85+
459
86
20.23
3.79
53
20
24,351
1,722
Causing adverse effects, erythromycin and  
other macrolides, oleandomycin, spiramycin
65–84
85+
1,340
349
35.88
9.35
100
44
134,634
15,323
Causing adverse effects, tetracycline group,  
doxycycline, minocycline, oxytetracycline
65–84
85+
590
176
30.71
9.16
61
29
35,785
5,112
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Principal diagnosis  Year of age  Total number  
of discharges
% of all discharges  
with ICD code
Charges, $ 
(mean)
Total cost 
Causing adverse effects, cephalosporin group,  
cepha-lexin, cephaloglycin, cephaloridine, cephalothin
65–84
85+
4,062
1,168
32.11
9.23
221
98
895,948
114,012
Causing adverse effects, antimycobacterial  
antibiotics, cycloserine, kanamycin, rifampin,  
streptomycin
65–84
85+
604
124
34.18
7.04
76
26
46,021
3,206
Causing adverse effects, antineoplastic antibiotics,  
actinomycins, such as bleomycin, cactinomycin,  
dactinomycin, daunorubicin, mitomycin
65–84 679 33.76 74 49,951
Causing adverse effects, other  
specified antibiotics
65–84
85+
16,502
5,191
34.28
10.78
733
282
12,102,073
1,462,584
Causing adverse effects, unspecified antibiotic 65–84
85+
8,151
2,571
40.87
12.89
429
174
3,499,517
446,829
Causing adverse effects, sulfonamides,  
sulfadiazine, sulfafurazole, sulfamethoxazole
65–84
85+
3,406
1,218
31.48
11.26
196
98
669,035
118,907
Causing adverse effects, quinoline  
and hydroxyquinoline derivatives,  
chiniofon, diiodohydroxyquinoline,
65–84
85+
287
80
44.00
12.30
49
20
14,166
15,71
Causing adverse effects, antimalarials and drugs acting 
on other blood protozoa, chloroquine phosphate, 
cycloguanil, primaquine, proguanil (chloroguanide), 
pyrimethamine
65–84
85+
323
59
39.45
7.22
45
17
14,522
1,017
Causing adverse effects, other antiprotozoal  
drugs, emetine
65–84
85+
1,287
345
35.82
9.61
101
45
130,356
15,444
Causing adverse effects, antiviral drugs, methisazone 65–84
85+
868
218
15.51
3.89
77
33
66,967
7,174
Causing adverse effects, other antimycobacterial  
drugs, ethambutol, ethionamide, isoniazid, sulfones, 
para-aminosalicylic acid derivatives
65–84 311 25.84 43 13,446
Causing adverse effects, other and unspecified  
anti-infectives, flucytosine, nitrofuran derivatives
65–84
85+
2,169
824
41.97
15.95
143
83
310,964
68,199
Causing adverse effects, adrenal cortical steroids,  
cortisone derivatives, desoxycorticosterone  
derivatives, fluorinated corticosteroids
65–84
85+
87,454
15,052
40.86
7.03
3,629
756
317,339,123
11,379,733
Causing adverse effects, androgens and anabolic  
congeners, nandrolone phenpropionate,  
oxymetholone, testosterone and preparations
65–84 78 43.28 20 1,537
Causing adverse effects, ovarian hormones and  
synthetic substitutes, contraceptives, oral,  
estrogens, estrogens and progestogens 
combined, progestogens
65–84
85+
364
98
14.80
3.98
42
24
15,214
2,361
Causing adverse effects, insulin and antidiabetic  
agents, acetohexamide, biguanide derivatives, oral,  
chlorpropamide, glucagon, insulin, phenformin
65–84
85+
17,195
4,006
53.12
12.37
752
234
12,930,202
936,802
Causing adverse effects, anterior pituitary 
hormones, corticotropin, gonadotropin,  
somatotropin (growth hormone)
65–84 63 17.15 19 1,171
Causing adverse effects, posterior  
pituitary hormones, vasopressin
65–84
85+
304
76
47.79
11.92
40
22
12,185
1,668
Causing adverse effects, parathyroid and  
parathyroid derivatives
65–84 78 48.15 19 1,515
Causing adverse effects, thyroid and  
thyroid derivatives, dextrothyroxine,  
levothyroxine sodium, liothyronine, thyroglobulin
65–84
85+
1,251
472
47.64
17.97
97
54
121,241
25,494
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Principal diagnosis  Year of age  Total number  
of discharges
% of all discharges  
with ICD code
Charges, $ 
(mean)
Total cost 
Causing adverse effects, antithyroid agents,  
iodides, thiouracil, thiourea
65–84 258 29.95 40 10,356
Causing adverse effects, other and unspecified  
hormones and synthetic substitutes
65–84 67 29.93 18 1,205
Causing adverse effects, antiallergic and  
antiemetic drugs, antihistamines,  
chlorpheniramine, diphenhydramine,  
diphenylpyraline, thonzylamine,  
tripelennamine
65–84
85+
3,152
784
39.07
9.72
190
72
600,190
56,309
Causing adverse effects, antineoplastic and  
immunosuppressive drugs, azathioprine, busulfan,  
chlorambucil, cyclophosphamide, cytarabine,  
fluorouracil, mercaptopurine
65–84
85+
66,481
4,265
39.53
2.54
3,155
250
209,744,458
1,066,938
Causing adverse effects, vitamins, not elsewhere  
classified, vitamin A, vitamin D,
65–84
85+
273
69
41.89
10.57
40
18
10,804
1,253
Causing adverse effects, iron and its compounds,  
ferric salts, ferrous sulphate, and other  
ferrous salts
65–84
85+
591
178
42.25
12.71
61
30
36,204
5,321
Causing adverse effects, liver preparations and  
other antianemic agents, folic acid
65–84 131 44.62 34 4,392
Causing adverse effects, anticoagulants,  
coumarin, heparin, phenindione, prothrombin  
synthesis  inhibitor, warfarin sodium
65–84
85+
94,793
31,807
55.65
18.67
4,264
1,498
404,165,145
47,642,222
Causing adverse effects, fibrinolysis-affecting  
drugs, aminocaproic acid, streptodornase,  
streptokinase, urokinase
65–84
85+
557
122
49.39
10.84
65
25
36,211
3,102
Causing adverse effects, anticoagulant  
antagonists and other coagulants,  
hexadimethrine bromide, protamine sulfate
65–84
85+
337
79
48.37
11.38
44
19
14,978
1,523
Causing adverse effects, gamma globulin 65–84 257 21.86 42 10,677
Causing adverse effects, natural blood and  
blood products, blood plasma, human fibrinogen
65–84
85+
1,169
247
33.15
7.02
93
39
108,702
9,713
Causing adverse effects, other agents affecting 
blood constituents, macromolecular  
blood substitutes
65–84
85+
6,532
1,442
52.09
11.50
343
103
2,238,266
149,039
Causing adverse effects, methadone 65–84
85+
654
95
26.60
3.86
63
23
40,926
2,157
Causing adverse effects, other opiates and related 
narcotics
65–84
85+
31,794
8,214
38.12
9.85
1,619
481
51,469,617
3,947,291
Causing adverse effects, salicylates,  
acetylsalicylic acid (aspirin), amino derivatives  
of salicylic acid, salicylic acid salts
65–84
85+
8,014
2,560
49.30
15.75
406
164
3,249,970
418,634
Causing adverse effects, aromatic analgesics,  
not elsewhere classified, acetanilid, paracetamol 
(acetaminophen), phenacetin (acetophenetidin)
65–84
85+
2,970
959
34.78
11.24
177
80
525,204
76,953
Causing adverse effects, antirheumatics  
(antiphlogistics), gold salts, indomethacin
65–84
85+
5,638
1,671
36.43
10.80
325
113
1,833,789
188,112
Causing adverse effects, other non-narcotic  
analgesics, pyrabital
65–84
85+
992
245
38.49
9.49
87
38
85,998
9,182
Causing adverse effects, other specified  
analgesics and antipyretics, pentazocine
65–84
85+
10,507
2,971
42.20
11.93
588
200
6,177,953
595,413
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Principal diagnosis  Year of age  Total number  
of discharges
% of all discharges  
with ICD code
Charges, $ 
(mean)
Total cost 
Causing adverse effects, unspecified analgesic and 
antipyretic
65–84
85+
13,539
3,513
41.33
10.72
645
206
8,728,366
725,273
Causing adverse effects, hydantoin derivatives,  
phenytoin
65–84
85+
8,344
1,909
35.40
8.10
372
119
3,108,179
227,128
Causing adverse effects, other and unspecified  
anticonvulsants, beclamide, primidone
65–84
85+
5,435
1,164
29.28
6.27
260
92
1,413,490
107,227
Causing adverse effects, anti-Parkinsonism  
drugs, amantadine, ethopropazine (profenamine),  
Levodopa (L-dopa)
65–84
85+
2,458
632
65.31
16.80
149
71
365,998
44,735
Causing adverse effects, barbiturates 65–84
85+
202
57
16.94
4.76
30
16
6,161
933
Causing adverse effects, other sedatives  
and hypnotics
65–84
85+
6,696
1,859
47.87
13.29
358
126
2,399,603
234,199
Causing adverse effects, sedatives and hypnotics 
unspecified, sleeping drug NOS, pill NOS,  
tablet nOS
65–84
85+
11,534
2,893
41.84
10.49
600
200
6,924,117
577,368
Causing adverse effects, central nervous system 
muscle-tone depressants, chlorphenesin (carbamate), 
mephenesin, methocarbamol
65–84
85+
336
53
39.60
6.24
48
16
16,070
838
Causing adverse effects, other gaseous anesthetics, 
ether, nitrous oxide, halogenated hydrocarbon  
derivatives, except halothane
65–84
85+
322
72
37.25
8.37
48
18
15,465
1,336
Causing adverse effects, intravenous anesthetics,  
ketamine, methohexital (methohexitone),  
thiobarbiturates, such as thiopental sodium
65–84
85+
905
138
39.12
5.96
86
27
78,077
3,735
Causing adverse effects, other and  
unspecified general anesthetics
65–84
85+
2,947
509
42.54
7.35
202
60
594,890
30,586
Causing adverse effects, surface and infiltration  
anesthetics, cocaine, lidocaine (lignocaine), 
procaine, tetracaine
65–84
85+
319
114
31.19
11.15
43
25
13,717
2,904
Causing adverse effects, peripheral nerve- and  
plexus-blocking anesthetics
65–84 341 37.40 46 15,595
Causing adverse effects, spinal anesthetics 65–84
85+
662
85
25.95
3.31
84
21
55,451
1,734
Causing adverse effects, antidepressants,  
amitriptyline, imipramine, monoamine oxidase  
(MAO) inhibitors
65–84
85+
5,471
1,985
38.92
14.12
281
132
1,538,923
261,560
Causing adverse effects, phenothiazine-based  
tranquilizers, chlorpromazine, fluphenazine,  
phenothiazine, prochlorperazine, promazine
65–84
85+
757
133
34.31
6.04
73
27
55,158
3,632
Causing adverse effects, butyrophenone-based  
tranquilizers, haloperidol, spiperone, trifluperidol
65–84
85+
1,142
509
35.43
15.81
87
57
99,298
29,253
Causing adverse effects, other antipsychotics, 
neuroleptics, and major tranquilizers
65–84
85+
4,745
1,666
31.01
10.89
243
122
1,154,744
203,698
Causing adverse effects, benzodiazepine-based  
tranquilizers, chlordiazepoxide, diazepam,  
flurazepam, lorazepam, medazepam, nitrazepam
65–84
85+
7,887
2,624
43.37
14.43
411
170
3,239,868
445,823
Causing adverse effects, other tranquilizers,  
hydroxyzine, meprobamate
65–84
85+
275
96
38.39
13.37
40
22
10,973
2,120
Causing adverse effects, psychostimulants,  
amphetamine, caffeine
65–84 286 20.50 40 11,507
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Principal diagnosis  Year of age  Total number  
of discharges
% of all discharges  
with ICD code
Charges, $ 
(mean)
Total cost 
Causing adverse effects, other psychotropic agents 65–84
85+
2,134
261
25.49
3.11
138
39
293,880
10,134
Causing adverse effects, unspecified  
psychotropic agent
65–84
85+
398
84
34.60
7.32
47
23
18,666
1,918
Causing adverse effects, opiate antagonists,  
levallorphan, nalorphine, naloxone
65–84
85+
688
151
38.88
8.55
91
32
62,649
4,836
Causing adverse effects, parasympathomimetics  
(cholinergics), acetylcholine, pilocarpine,  
anticholinesterase: organophosphorus, reversible
65–84
85+
1,185
671
56.06
31.74
89
66
105,341
44,481
Causing adverse effects, parasympatholytics  
(anticholinergics and antimuscarinics) and  
spasmolytics, atropine, homatropine,  
hyoscine (scopolamine),  
quaternary ammonium derivatives
65–84
85+
903
416
38.06
17.55
79
48
71,380
19,959
Causing adverse effects, sympathomimetics  
(adrenergics), epinephrine (adrenalin),  
levarterenol (noradrenalin)
65–84
85+
2,985
799
43.47
11.63
201
74
599,321
59,397
Causing adverse effects, sympatholytics (antiadrener-
gics), phenoxybenzamine, tolazoline hydrochloride
65–84
85+
6,924
2,307
57.95
19.31
366
161
2,532,698
372,178
Causing adverse effects, unspecified drug primarily 
affecting the autonomic nervous system
65–84 63 37.75 17 1,070
Causing adverse effects, cardiac rhythm regulators, 
practolol, procainamide, propranolol, quinidine
65–84
85+
10,267
2,634
60.63
15.55
524
160
5,378,051
422,553
Causing adverse effects, cardiotonic glycosides and 
drugs of similar action, digitalis glycosides, digoxin, 
strophanthins
65–84
85+
19,375
11,179
56.72
32.73
723
467
14,004,365
5,217,237
Causing adverse effects, antilipemic and  
antiarteriosclerotic drugs, cholestyramine,  
clofibrate
65–84
85+
5,398
899
51.21
8.52
284
83
1,534,558
74,858
Causing adverse effects, coronary vasodilators,  
dipyridamole, nitrates (nitroglycerin),  
nitrites, prenylamine
65–84
85+
6,480
2,136
44.93
14.81
337
140
2,183,971
298,336
Causing adverse effects, other vasodilators,  
cyclandelate, diazoxide, hydralazine, papaverine
65–84
85+
494
111
39.18
8.77
61
23
29,933
2,592
Causing adverse effects, other antihypertensive  
agents, clonidine, guanethidine, rauwolfia 
alkaloids, reserpine
65–84
85+
20,725
7,486
49.78
17.98
1,036
406
21,467,546
3,041,078
Causing adverse effects, other and  
unspecified agents primarily affecting the  
cardiovascular system
65–84
85+
17,374
5,989
50.10
17.27
836
348
14,524,755
2,086,797
Causing adverse effects, antacids and  
antigastric secretion drugs, aluminum  
hydroxide, magnesium trisilicate
65–84
85+
1,079
338
39.79
12.46
91
49
98,075
16,579
Causing adverse effects, irritant cathartics,  
bisacodyl, castor oil, phenolphthalein
65–84
85+
168
80
47.51
22.62
31
21
5,242
1,678
Causing adverse effects, emollient  
cathartics, sodium dioctyl sulfosuccinate
65–84
85+
150
86
42.17
24.20
28
21
4,259
1,788
Causing adverse effects, other cathartics,  
including intestinal atonia drugs,  
magnesium sulfate
65–84
85+
1,016
403
43.38
17.22
92
46
93,400
18,356
Causing adverse effects, antidiarrheal drugs,  
bismuth subcarbonate, kaolin, pectin
65–84
85+
332
100
49.75
14.92
40
23
13,180
2,320
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Principal diagnosis  Year of age  Total number  
of discharges
% of all discharges  
with ICD code
Charges, $ 
(mean)
Total cost 
Causing adverse effects, other specified agents  
primarily affecting the gastrointestinal system
65–84
85+
406
101
39.70
9.84
52
24
21,122
2,366
Causing adverse effects, purine derivative diuretics, 
theobromine, theophylline
65–84
85+
915
116
62.67
7.96
82
24
74,956
2,732
Causing adverse effects, carbonic acid anhydrase  
inhibitors, acetazolamide
65–84
85+
188
77
37.90
15.58
34
20
6,432
1,571
Causing adverse effects, saluretics,  
benzothiadiazides, chlorothiazide group
65–84
85+
11,695
4,086
52.12
18.21
639
258
7,473,166
1,053,977
Causing adverse effects, other diuretics,  
ethacrynic acid, furosemide
65–84
85+
29,655
12,883
50.65
22.00
1,582
763
46,906,127
9,836,264
Causing adverse effects, electrolytic, caloric,  
and water-balance agents
65–84
85+
1,482
500
39.99
13.49
110
63
162,501
31,367
Causing adverse effects, uric acid metabolism  
drugs, phenoquin, probenecid
65–84
85+
1,793
493
53.53
14.70
122
53
218,118
25,978
Causing adverse effects, smooth muscle relaxants, 
adiphenine, metaproterenol (orciprenaline)
65–84
85+
647
274
53.92
22.83
63
39
41,025
10,634
Causing adverse effects, skeletal muscle relaxants, 
alcuronium chloride, uxamethonium chloride
65–84
85+
1,041
261
38.85
9.74
78
37
81,130
9,721
Causing adverse effects, other and  
unspecified drugs acting on muscles
65–84 162 46.82 29 4,779
Causing adverse effects, antitussives,  
dextromethorphan, pipazethate hydrochloride
65–84 167 45.58 30 5,019
Causing adverse effects, expectorants,  
acetylcysteine, cocillana, terpin hydrate
65–84 149 39.05 26 3,908
Causing adverse effects, antiasthmatics,  
aminophylline (theophylline ethylenediamine)
65–84
85+
1,478
327
31.33
6.94
110
40
162,174
13,112
Causing adverse effects, other and unspecified  
respiratory drugs
65–84 146 62.06 30 4,350
Causing adverse effects, local anti-infectives  
and anti-inflammatory drugs
65–84
85+
1,237
243
35.48
6.98
110
44
136,261
10,786
Causing adverse effects, antipruritics 65–84 71 46.11 19 1,347
Causing adverse effects, emollients, demulcents,  
and protectants
65–84 96 37.12 21 2,053
Causing adverse effects, eye anti-infectives and  
other eye drugs, idoxuridine
65–84
85+
129
108
33.84
28.15
27
22
3,481
2,411
Causing adverse effects, anti-infectives and other  
drugs and preparations for ear, nose, and throat
65–84 346 36.83 75 25,972
Causing adverse effects, other drugs and  
medicinal substances, contrast media used for  
diagnostic x-ray procedures,  
diagnostic agents and kits
65–84
85+
27,976
6,268
44.77
10.03
1,270
345
35,520,572
2,160,531
Causing adverse effects, unspecified  
drug or medicinal substance
65–84
85+
18,682
4,891
41.54
10.88
810
282
15,133,675
1,379,955
Causing adverse effects, BCg vaccine 65–84 96 63.05 24 2,319
Causing adverse effects, other and  
unspecified bacterial vaccines
65–84 156 39.47 31 4,803
Causing adverse effects, other and unspecified viral  
and rickettsial vaccines, mumps vaccine
65–84 194 38.33 33 6,300
Causing adverse effects, other and unspecified  
vaccines and biologic substances
65–84 138 22.62 27 3,729
Total   791,931     937,795,690
Abbreviations: NOS, not otherwise specified; BCG, Bacillus Calmette-Guérin.Clinical Pharmacology: Advances and Applications 2010:2 54
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Appendix
Table 1 The International Classification of Diseases, 9 Revision, Clinical Modification (iCD-9-CM) codes related to adverse drug effects, 
principal diagnosis
ICD code Principal diagnosis
535.40 Oth Spf gstrt W/O hmrhg specified gastritis; without mention of hemorrhage
535.41 Oth Spf gastrt W hmrhg specified gastritis; with hemorrhage
962.3 Poison-insulin/Antidiab Poisoning by; insulins and antidiabetic agents, Acetohexamide, Biguanide derivatives, oral,  
Chlorpropamide, glucagon, insulin, Phenformin
962.7 Poisoning-Thyroid/Deriv Poisoning by; thyroid and thyroid derivatives, Dextrothyroxin, Levothyroxine sodium,  
Liothyronine, Thyroglobulin
963.0 Pois-Antiallrg/Antiemet Poisoning by; antiallergic and antiemetic drugs, Antihistamines, Chlorpheniramine,  
Diphenhydramine, Diphenylpyraline, Thonzylamine, Tripelennamine
963.1 Pois-Antineopl/immunosup Poisoning by; antineoplastic and immunosuppressive drugs, Azathioprine, Busulfan, Chlorambucil,  
Cyclophosphamide, Cytarabine, Fluorouracil
964.2 Poisoning-Anticoagulants Poisoning by; anticoagulants, Coumarin, Heparin, Phenindione, Warfarin sodium
965.00 Poisoning-Opium nos Poisoning by; opium (alkaloids), unspecified
965.02 Poisoning-Methadone Poisoning by; methadone
965.09 Poisoning-Opiates nec Poisoning by opiates and related narcotics; other, Meperidine [pethidine], Morphine
965.1 Poisoning-Salicylates Poisoning by; salicylates, Acetylsalicylic acid [aspirin], Salicylic acid salts
965.4 Pois-Arom Analgesics nec Poisoning by; aromatic analgesics, not elsewhere classified, Acetanilid, Paracetamol [acetaminophen],  
Phenacetin [acetophenetidin]
965.61 Pois-Propionic Acid Derv Poisoning by; propionic acid derivatives, Fenoprofen, Flurbiprofen, Ibuprofen, Ketoprofen,  
naproxen, Oxaprozin
965.8 Pois-Analges/Antipyr nec Poisoning by; other specified analgesics and antipyretics; Pentazocine
965.9 Pois-Analges/Antipyr nos Poisoning by; unspecified analgesic and antipyretic
966.1 Poison-hydantoin Derivat Poisoning by; hydantoin derivatives, Phenytoin
966.3 Pois-Anticonvul nec/nos Poisoning by; other and unspecified anticonvulsants
966.4 Pois-Anti-Parkinson Drug Poisoning by; anti-Parkinsonism drugs, Amantadine, Ethopropazine [profenamine], Levodopa [L-dopa]
967.0 Poisoning-Barbiturates Poisoning by; barbiturates, Amobarbital [amylobarbitone], Barbital [barbitone], Butabarbital  
[butabarbitone], Pentobarbital [pentobarbitone], Phenobarbital [phenobarbitone]
967.8 Pois-Sedative/hypnot nec Poisoning by; other sedatives and hypnotics
967.9 Pois-Sedative/hypnot nos Poisoning by; unspecified sedative or hypnotic, Sleeping: drug NOS, pill NOS, tablet NOS
968.0 Pois-Cns Muscle Depress Poisoning by; central nervous system muscle-tone depressants, Chlorphenesin (carbamate), Mephenesin, 
Methocarbamol
968.5 Pois-Topic/Infilt Anesth Poisoning by; surface [topical] and infiltration anesthetics, Cocaine, Lidocaine [lignocaine],  
Procaine, Tetracaine
969.0 Poisoning-Antidepressant Poisoning by; antidepressants, Amitriptyline, Imipramine, Monoamine oxidase [MAO] inhibitors
969.1 Pois-Phenothiazine Tranq Poisoning by; phenothiazine-based tranquilizers, Chlorpromazine, Fluphenazine, Prochlorperazine,  
Promazine
969.3 Poison-Antipsychotic nec Poisoning by; other antipsychotics, neuroleptics, and major tranquilizers
969.4 Pois-Benzodiazepine Tran Poisoning by; benzodiazepine-based tranquilizers, Chlordiazepoxide, Diazepam, Flurazepam, Lorazepam, 
Medazepam, nitrazepam
969.5 Poison-Tranquilizer nec Poisoning by; other tranquilizers, Hydroxyzine, Meprobamate
969.8 Poison-Psychotropic nec Poisoning by; other specified psychotropic agents
970.8 Pois-Cns Stimulants nec Poisoning by; other specified central nervous system stimulants
971.3 Poisoning-Sympatholytics Poisoning by; sympatholytics [antiadrenergics], Phenoxybenzamine, Tolazoline hydrochloride
972.0 Pois-Card rhythm regulat Poisoning by; cardiac rhythm regulators, Practolol, Procainamide, Propranolol, Quinidine
972.1 Poisoning-Cardiotonics Poisoning by; cardiotonic glycosides and drugs of similar action, Digitalis glycosides, Digoxin,  
Strophanthins
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ICD code Principal diagnosis
972.4 Pois-Coronary Vasodilat Poisoning by; coronary vasodilators, Dipyridamole, Nitrates [nitroglycerin], Nitrites
972.6 Pois-Antihyperten Agent Poisoning by; other antihypertensive agents, Guanethidine, Rauwolfia alkaloids, Reserpine
972.9 Pois-Cardiovasc Agt nec Poisoning by; other and unspecified agents primarily affecting the cardiovascular system
974.3 Poisoning-Saluretics Poisoning by; saluretics, Benzothiadiazides, Chlorothiazide group
974.4 Poisoning-Diuretics nec Poisoning by; other diuretics, Ethacrynic acid, Furosemide
975.2 Pois-Skelet Muscle relax Poisoning by; skeletal muscle relaxants
977.8 Poison-Medicinal Agt nec Poisoning by; other specified drugs and medicinal substances, Diagnostic agents and kits
Table 2 The International Classification of Diseases, 9 Revision, Clinical Modification (iCD-9-CM) codes related to adverse treatment effects, 
all listed diagnoses
ICD code Diagnoses
e850.1 Acc Poison-Methadone Accidental poisoning by; methadone
e850.2 Acc Poison-Opiates nec Accidental poisoning by; other opiates and related narcotics, Morphine, Opium (alkaloids)
e850.2 Acc Poison-Opiates nec Accidental poisoning by; other opiates and related narcotics, Morphine, Opium (alkaloids)
e850.3 Acc Poison-Salicylates Accidental poisoning by; salicylates, Acetylsalicylic acid [aspirin], Salicylic acid salts, Amino derivatives of 
salicylic acid
e850.3 Acc Poison-Salicylates Accidental poisoning by; salicylates, Acetylsalicylic acid [aspirin], Salicylic acid salts, Amino derivatives of 
salicylic acid
e850.4 Acc Poison-Arom Analgesc Accidental poisoning by; aromatic analgesics, not elsewhere classified, Acetanilid, Paracetamol  
[acetaminophen], Phenacetin [acetophenetidin]
e850.4 Acc Poison-Arom Analgesc Accidental poisoning by; aromatic analgesics, not elsewhere classified, Acetanilid, Paracetamol  
[acetaminophen], Phenacetin [acetophenetidin]
e850.6 Acc Poison-Antirheumatic Accidental poisoning by; antirheumatics [antiphlogistics], Gold salts, Indomethacin
e850.8 Acc Poison-Analgesic nec Accidental poisoning by; other specified analgesics and antipyretics, Pentazocine
e850.8 Acc Poison-Analgesic nec Accidental poisoning by; other specified analgesics and antipyretics, Pentazocine
e850.9 Acc Poison-Analgesic nos Accidental poisoning by; unspecified analgesic or antipyretic
e851 Acc Poison-Barbiturates Accidental poisoning by barbiturates
e852.8 Acc Poison-Sedatives nec Accidental poisoning by; other specified sedatives and hypnotics
e852.8 Acc Poison-Sedatives nec Accidental poisoning by; other specified sedatives and hypnotics
e852.9 Acc Poison-Sedatives nos Accidental poisoning by; unspecified sedative or hypnotic, Sleeping: drug NOS, pill NOS, tablet NOS
e852.9 Acc Poison-Sedatives nos Accidental poisoning by; unspecified sedative or hypnotic, Sleeping: drug NOS, pill NOS, tablet NOS
e853.2 Acc Poisn-Benzdiaz Tranq Accidental poisoning by; benzodiazepine-based tranquilizers, Chlordiazepoxide, Diazepam, Flurazepam, 
Lorazepam, Medazepam, nitrazepam
e853.2 Acc Poisn-Benzdiaz Tranq Accidental poisoning by; benzodiazepine-based tranquilizers, Chlordiazepoxide, Diazepam, Flurazepam, 
Lorazepam, Medazepam, nitrazepam
e853.8 Acc Poisn-Tranquilzr nec Accidental poisoning by; other specified tranquilizers, Hydroxyzine, Meprobamate
e853.8 Acc Poisn-Tranquilzr nec Accidental poisoning by; other specified tranquilizers, Hydroxyzine, Meprobamate
e854.0 Acc Poison-Antidepressnt Accidental poisoning by; antidepressants, Amitriptyline, Imipramine, Monoamine oxidase [MAO] inhibitors
e854.0 Acc Poison-Antidepressnt Accidental poisoning by; antidepressants, Amitriptyline, Imipramine, Monoamine oxidase [MAO] inhibitors
e854.2 Acc Poisn-Psychstimulant Accidental poisoning by; psychostimulants, Amphetamine, Caffeine
e854.3 Acc Poison-Cns Stimulant Accidental poisoning by; central nervous system stimulants, Analeptics, Opiate antagonists
e854.8 Acc Poisn Psychotrop nec Accidental poisoning by; other psychotropic agents
e855.0 Acc Poisn-Anticonvulsant Accidental poisoning by; anticonvulsant and anti-Parkinsonism drugs, Amantadine, Hydantoin derivatives, 
Oxazolidine derivatives [paramethadione] [trimethadione]
e855.0 Acc Poisn-Anticonvulsant Accidental poisoning by; anticonvulsant and anti-Parkinsonism drugs, Amantadine, Hydantoin derivatives, 
Oxazolidine derivatives [paramethadione] [trimethadione]
e855.1 Acc Poisn-Cns Depres nec Accidental poisoning by; other central nervous system depressants, Ether, Gaseous anesthetics,  
halogenated hydrocarbon derivatives, intravenous anesthetics, Thiobarbiturates
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e855.3 Acc Poison-Cholinergics Accidental poisoning by; parasympathomimetics [cholinergics], Acetylcholine, Pilocarpine,  
Anticholinesterase: organophosphorus, reversible
e855.6 Acc Poisn-Sympatholytics Accidental poisoning by; sympatholytics [antiadrenergics], Phenoxybenzamine, Tolazoline hydrochloride
e855.6 Acc Poisn-Sympatholytics Accidental poisoning by; sympatholytics [antiadrenergics], Phenoxybenzamine, Tolazoline hydrochloride
e856 Acc Poison-Antibiotics Accidental poisoning by antibiotics
e857 Acc Pois-Oth Anti-infect Accidental poisoning by other anti-infectives
e858.0 Acc Poison-hormones Accidental poisoning by; hormones and synthetic substitutes
e858.0 Acc Poison-hormones Accidental poisoning by; hormones and synthetic substitutes
e858.1 Acc Poisn-Systemic Agent Accidental poisoning by; primarily systemic agents
e858.2 Acc Poison-Blood Agent Accidental poisoning by; agents primarily affecting blood constituents
e858.2 Acc Poison-Blood Agent Accidental poisoning by; agents primarily affecting blood constituents
e858.3 Acc Poisn-Cardiovasc Agt Accidental poisoning by; agents primarily affecting cardiovascular system
e858.3 Acc Poisn-Cardiovasc Agt Accidental poisoning by; agents primarily affecting cardiovascular system
e858.4 Acc Poison-gi Agent Accidental poisoning by; agents primarily affecting gastrointestinal system
e858.4 Acc Poison-gi Agent Accidental poisoning by; agents primarily affecting gastrointestinal system
e858.5 Acc Poisn-Metabol Agnt Accidental poisoning by; water, mineral, and uric acid metabolism drugs
e858.5 Acc Poisn-Metabol Agnt Accidental poisoning by; water, mineral, and uric acid metabolism drugs
e858.6 Acc Poisn-Muscl/resp Agt Accidental poisoning by; agents primarily acting on the smooth and skeletal muscles and respiratory 
system
e858.7 Acc Poisn-Skin/eent Agnt Accidental poisoning by; agents primarily affecting skin and mucous membrane,  
ophthalmological, otorhinolaryngological, and dental drugs
e858.8 Acc Poisoning-Drug nec Accidental poisoning by; other specified drugs, Central appetite depressants
e858.8 Acc Poisoning-Drug nec Accidental poisoning by; other specified drugs, Central appetite depressants
e858.9 Acc Poisoning-Drug nos Accidental poisoning by; unspecified drug
e858.9 Acc Poisoning-Drug nos Accidental poisoning by; unspecified drug
e870.0 Acc Cut/hem in Surgery Accidental cut, puncture, perforation, or hemorrhage during; surgical operation
e870.0 Acc Cut/hem in Surgery Accidental cut, puncture, perforation, or hemorrhage during; surgical operation
e870.4 Acc Cut/hem W Scope exam Accidental cut, puncture, perforation, or hemorrhage during; endoscopic examination
e870.4 Acc Cut/hem W Scope exam Accidental cut, puncture, perforation, or hemorrhage during; endoscopic examination
e870.5 Acc Cut/hem W Catheteriz Accidental cut, puncture, perforation, or hemorrhage during; aspiration of fluid or tissue,  
puncture, and catheterization, Abdominal paracentesis, Aspirating needle biopsy, Blood sampli
e870.6 Acc Cut/hem W heart Cath Accidental cut, puncture, perforation, or hemorrhage during; heart catheterization
e870.6 Acc Cut/hem W heart Cath Accidental cut, puncture, perforation, or hemorrhage during; heart catheterization
e870.8 Acc Cut in Med Care nec Accidental cut, puncture, perforation, or hemorrhage during; other specified medical care
e870.8 Acc Cut in Med Care nec Accidental cut, puncture, perforation, or hemorrhage during; other specified medical care
e870.9 Acc Cut in Med Care nos Accidental cut, puncture, perforation, or hemorrhage during; unspecified medical care
e871.0 Post-Surgical Forgn Body Foreign object left in body during; surgical operation
e871.8 Post-Op Foreign Body nec Foreign object left in body during; other specified procedures
e874.0 instrmnt Fail in Surgery Mechanical failure of instrument or apparatus during; surgical operation
e874.8 instrmnt Fail-Proced nec Mechanical failure of instrument or apparatus during; other specified procedures
e876.8 Medical Misadventure nec Other specified misadventures during medical care, Performance of inappropriate treatment NEC
e876.8 Medical Misadventure nec Other specified misadventures during medical care, Performance of inappropriate treatment NEC
e876.9 Medical Misadventure nos Unspecified misadventure during medical care
e876.9 Medical Misadventure nos Unspecified misadventure during medical care
e930.0 Adv eff Penicillins Causing adverse effects; penicillins, Natural, Synthetic, Semisynthetic, such as: ampicillin, cloxacillin, nafcillin, 
oxacillin
e930.0 Adv eff Penicillins Causing adverse effects; penicillins, Natural, Synthetic, Semisynthetic, such as: ampicillin, cloxacillin, nafcillin, 
oxacillin
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e930.1 Adv eff Antifung Antbiot Causing adverse effects; antifungal antibiotics
e930.1 Adv eff Antifung Antbiot Causing adverse effects; antifungal antibiotics
e930.3 Adv eff erythromycin Causing adverse effects; erythromycin and other macrolides, Oleandomycin, Spiramycin
e930.3 Adv eff erythromycin Causing adverse effects; erythromycin and other macrolides, Oleandomycin, Spiramycin
e930.4 Adv eff Tetracycline Causing adverse effects; tetracycline group, Doxycycline, Minocycline, Oxytetracycline
e930.4 Adv eff Tetracycline Causing adverse effects; tetracycline group, Doxycycline, Minocycline, Oxytetracycline
e930.5 Adv eff Cephalosporin Causing adverse effects; cephalosporin group, Cephalexin, Cephaloglycin, Cephaloridine, Cephalothin
e930.5 Adv eff Cephalosporin Causing adverse effects; cephalosporin group, Cephalexin, Cephaloglycin, Cephaloridine, Cephalothin
e930.6 Adv eff Antmycob Antbiot Causing adverse effects; antimycobacterial antibiotics, Cycloserine, Kanamycin, Rifampin, Streptomycin
e930.6 Adv eff Antmycob Antbiot Causing adverse effects; antimycobacterial antibiotics, Cycloserine, Kanamycin, Rifampin, Streptomycin
e930.7 Adv eff Antineop Antbiot Causing adverse effects; antineoplastic antibiotics, Actinomycins, such as: Bleomycin, Cactinomycin,  
Dactinomycin, Daunorubicin, Mitomycin
e930.8 Adv eff Antibiotics nec Causing adverse effects; other specified antibiotics
e930.8 Adv eff Antibiotics nec Causing adverse effects; other specified antibiotics
e930.9 Adv eff Antibiotic nos Causing adverse effects; unspecified antibiotic
e930.9 Adv eff Antibiotic nos Causing adverse effects; unspecified antibiotic
e931.0 Adv eff Sulfonamides Causing adverse effects; sulfonamides, Sulfadiazine, Sulfafurazole, Sulfamethoxazole
e931.0 Adv eff Sulfonamides Causing adverse effects; sulfonamides, Sulfadiazine, Sulfafurazole, Sulfamethoxazole
e931.3 Adv eff Quinoline Causing adverse effects; quinoline and hydroxyquinoline derivatives, Chiniofon, Diiodohydroxyquin
e931.3 Adv eff Quinoline Causing adverse effects; quinoline and hydroxyquinoline derivatives, Chiniofon, Diiodohydroxyquin
e931.4 Adv eff Antimalarials Causing adverse effects; antimalarials and drugs acting on other blood protozoa, Chloroquine phosphate, 
Cycloguanil, Primaquine, Proguanil [chloroguanide], Pyrimethamine
e931.4 Adv eff Antimalarials Causing adverse effects; antimalarials and drugs acting on other blood protozoa, Chloroquine phosphate, 
Cycloguanil, Primaquine, Proguanil [chloroguanide], Pyrimethamine
e931.5 Adv eff Antprotazoal nec Causing adverse effects; other antiprotozoal drugs, Emetine
e931.5 Adv eff Antprotazoal nec Causing adverse effects; other antiprotozoal drugs, Emetine
e931.7 Adv eff Antiviral Drugs Causing adverse effects; antiviral drugs, Methisazone
e931.7 Adv eff Antiviral Drugs Causing adverse effects; antiviral drugs, Methisazone
e931.8 Adv eff Antimycobac nec Causing adverse effects; other antimycobacterial drugs, Ethambutol, Ethionamide, Isoniazid, Sulfones,  
Para-aminosalicylic acid derivatives
e931.9 Adv eff Antinfct nec/nos Causing adverse effects; other and unspecified anti-infectives, Flucytosine, Nitrofuran derivatives
e931.9 Adv eff Antinfct nec/nos Causing adverse effects; other and unspecified anti-infectives, Flucytosine, Nitrofuran derivatives
e932.0 Adv eff Corticosteroids Causing adverse effects; adrenal cortical steroids, Cortisone derivatives, Desoxycorticosterone derivatives, 
Fluorinated corticosteroids
e932.0 Adv eff Corticosteroids Causing adverse effects; adrenal cortical steroids, Cortisone derivatives, Desoxycorticosterone derivatives, 
Fluorinated corticosteroids
e932.1 Adv eff Androgens Causing adverse effects; androgens and anabolic congeners, Nandrolone phenpropionate, Oxymetholone, 
Testosterone and preparations
e932.2 Adv eff Ovarian hormones Causing adverse effects; ovarian hormones and synthetic substitutes, Contraceptives, oral, Estrogens,  
estrogens and progestogens combined, Progestogens
e932.2 Adv eff Ovarian hormones Causing adverse effects; ovarian hormones and synthetic substitutes, Contraceptives, oral, Estrogens,  
estrogens and progestogens combined, Progestogens
e932.3 Adv eff insulin/Antidiab Causing adverse effects; insulins and antidiabetic agents, Acetohexamide, Biguanide derivatives, oral,  
Chlorpropamide, glucagon, insulin, Phenformin
e932.3 Adv eff insulin/Antidiab Causing adverse effects; insulins and antidiabetic agents, Acetohexamide, Biguanide derivatives, oral,  
Chlorpropamide, glucagon, insulin, Phenformin
e932.4 Adv eff Ant Pituitary Causing adverse effects; anterior pituitary hormones, Corticotropin, Gonadotropin, Somatotropin  
[growth hormone]
e932.5 Adv eff Post Pituitary Causing adverse effects; posterior pituitary hormones, Vasopressin
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e932.5 Adv eff Post Pituitary Causing adverse effects; posterior pituitary hormones, Vasopressin
e932.6 Adv eff Parathyroid Causing adverse effects; parathyroid and parathyroid derivatives
e932.7 Adv eff Thyroid Deriv Causing adverse effects; thyroid and thyroid derivatives, Dextrothyroxine, Levothyroxine sodium,  
Liothyronine, Thyroglobulin
e932.7 Adv eff Thyroid Deriv Causing adverse effects; thyroid and thyroid derivatives, Dextrothyroxine, Levothyroxine sodium,  
Liothyronine, Thyroglobulin
e932.8 Adv eff Antithyroid Agnt Causing adverse effects; antithyroid agents, Iodides, Thiouracil, Thiourea
e932.9 Adv eff hormones nec/nos Causing adverse effects; other and unspecified hormones and synthetic substitutes
e933.0 Adv eff Anallrg/Antemet Causing adverse effects; antiallergic and antiemetic drugs, Antihistamines, Chlorpheniramine,  
Diphenhydramine, Diphenylpyraline, Thonzylamine, Tripelennami
e933.0 Adv eff Anallrg/Antemet Causing adverse effects; antiallergic and antiemetic drugs, Antihistamines, Chlorpheniramine,  
Diphenhydramine, Diphenylpyraline, Thonzylamine, Tripelennami
e933.1 Adv eff Antineoplastic Causing adverse effects; antineoplastic and immunosuppressive drugs, Azathioprine, Busulfan, Chlorambucil, 
Cyclophosphamide, Cytarabine, Fluorouracil, Mercaptopurine
e933.1 Adv eff Antineoplastic Causing adverse effects; antineoplastic and immunosuppressive drugs, Azathioprine, Busulfan, Chlorambucil, 
Cyclophosphamide, Cytarabine, Fluorouracil, Mercaptopurine
e933.5 Adv eff Vitamins nec Causing adverse effects; vitamins, not elsewhere classified, Vitamin A, Vitamin D
e933.5 Adv eff Vitamins nec Causing adverse effects; vitamins, not elsewhere classified, Vitamin A, Vitamin D
e934.0 Adv eff iron Compounds Causing adverse effects; iron and its compounds, Ferric salts, Ferrous sulphate and other ferrous salts
e934.0 Adv eff iron Compounds Causing adverse effects; iron and its compounds, Ferric salts, Ferrous sulphate and other ferrous salts
e934.1 Adv eff Liver/Antianemic Causing adverse effects; liver preparations and other antianemic agents, Folic acid
e934.2 Adv eff Anticoagulants Causing adverse effects; anticoagulants, Coumarin, Heparin, Phenindione, Prothrombin synthesis inhibitor, 
Warfarin sodium
e934.2 Adv eff Anticoagulants Causing adverse effects; anticoagulants, Coumarin, Heparin, Phenindione, Prothrombin synthesis inhibitor, 
Warfarin sodium
e934.4 Adv eff Fibrinolysis Agt Causing adverse effects; fibrinolysis-affecting drugs, Aminocaproic acid, Streptodornase, Streptokinase, 
Urokinase
e934.4 Adv eff Fibrinolysis Agt Causing adverse effects; fibrinolysis-affecting drugs, Aminocaproic acid, Streptodornase, Streptokinase, 
Urokinase
e934.5 Adv eff Coagulants Causing adverse effects; anticoagulant antagonists and other coagulants, Hexadimethrine bromide,  
Protamine sulfate
e934.5 Adv eff Coagulants Causing adverse effects; anticoagulant antagonists and other coagulants, Hexadimethrine bromide,  
Protamine sulfate
e934.6 Adv eff gamma globulin Causing adverse effects; gamma globulin
e934.7 Adv eff Blood Products Causing adverse effects; natural blood and blood products, Blood plasma, Human fibrinogen
e934.7 Adv eff Blood Products Causing adverse effects; natural blood and blood products, Blood plasma, Human fibrinogen
e934.8 Adv eff Blood Agent nec Causing adverse effects; other agents affecting blood constituents, Macromolecular blood substitutes
e934.8 Adv eff Blood Agent nec Causing adverse effects; other agents affecting blood constituents, Macromolecular blood substitutes
e935.1 Adv eff Methadone Causing adverse effects; methadone
e935.1 Adv eff Methadone Causing adverse effects; methadone
e935.2 Adv eff Opiates Causing adverse effects; other opiates and related narcotics
e935.2 Adv eff Opiates Causing adverse effects; other opiates and related narcotics
e935.3 Adv eff Salicylates Causing adverse effects; salicylates, Acetylsalicylic acid [aspirin], Amino derivatives of salicylic acid, Salicylic 
acid salts
e935.3 Adv eff Salicylates Causing adverse effects; salicylates, Acetylsalicylic acid [aspirin], Amino derivatives of salicylic acid, Salicylic 
acid salts
e935.4 Adv eff Arom Analgsc nec Causing adverse effects; aromatic analgesics, not elsewhere classified, Acetanilid, Paracetamol  
[acetaminophen], Phenacetin [acetophenetidin]
e935.4 Adv eff Arom Analgsc nec Causing adverse effects; aromatic analgesics, not elsewhere classified, Acetanilid, Paracetamol  
[acetaminophen], Phenacetin [acetophenetidin]
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e935.6 Adv eff Antirheumatics Causing adverse effects; antirheumatics [antiphlogistics], Gold salts, Indomethacin
e935.6 Adv eff Antirheumatics Causing adverse effects; antirheumatics [antiphlogistics], Gold salts, Indomethacin
e935.7 Adv eff non-narc Analgsc Causing adverse effects; other non-narcotic analgesics, Pyrabital
e935.7 Adv eff non-narc Analgsc Causing adverse effects; other non-narcotic analgesics, Pyrabital
e935.8 Adv eff Analgesics nec Causing adverse effects; other specified analgesics and antipyretics, Pentazocine
e935.8 Adv eff Analgesics nec Causing adverse effects; other specified analgesics and antipyretics, Pentazocine
e935.9 Adv eff Analgesic nos Causing adverse effects; unspecified analgesic and antipyretic
e935.9 Adv eff Analgesic nos Causing adverse effects; unspecified analgesic and antipyretic
e936.1 Adv eff hydantoin Deriv Causing adverse effects; hydantoin derivatives, Phenytoin
e936.1 Adv eff hydantoin Deriv Causing adverse effects; hydantoin derivatives, Phenytoin
e936.3 Adv eff Antconvl nec/nos Causing adverse effects; other and unspecified anticonvulsants, Beclamide, Primidone
e936.3 Adv eff Antconvl nec/nos Causing adverse effects; other and unspecified anticonvulsants, Beclamide, Primidone
e936.4 Adv eff Anti-Parkinson ausing adverse effects; anti-Parkinsonism drugs, Amantadine, Ethopropazine [profenamine],  
Levodopa [L-dopa]
e936.4 Adv eff Anti-Parkinson ausing adverse effects; anti-Parkinsonism drugs, Amantadine, Ethopropazine [profenamine],  
Levodopa [L-dopa]
e937.0 Adv eff Barbiturates Causing adverse effects; barbiturates
e937.0 Adv eff Barbiturates Causing adverse effects; barbiturates
e937.8 Adv eff Sedat/hypnot nec Causing adverse effects; other sedatives and hypnotics
e937.8 Adv eff Sedat/hypnot nec Causing adverse effects; other sedatives and hypnotics
e937.9 Adv eff Sedat/hypnot nos Causing adverse effects; sedatives and hypnotics; unspecified, Sleeping: drug NOS, pill NOS, tablet NOS
e937.9 Adv eff Sedat/hypnot nos Causing adverse effects; sedatives and hypnotics; unspecified, Sleeping: drug NOS, pill NOS, tablet NOS
e938.0 Adv eff Cns Muscl Depres Causing adverse effects; central nervous system muscle-tone depressants, Chlorphenesin (carbamate), 
Mephenesin, Methocarbamol
e938.0 Adv eff Cns Muscl Depres Causing adverse effects; central nervous system muscle-tone depressants, Chlorphenesin (carbamate), 
Mephenesin, Methocarbamol
e938.2 Adv eff gas Anesthet nec Causing adverse effects; other gaseous anesthetics, Ether, Nitrous oxide, Halogenated hydrocarbon  
derivatives, except halothane
e938.2 Adv eff gas Anesthet nec Causing adverse effects; other gaseous anesthetics, Ether, Nitrous oxide, Halogenated hydrocarbon  
derivatives, except halothane
e938.3 Adv eff intraven Anesth Causing adverse effects; intravenous anesthetics, Ketamine, Methohexital [methohexitone],  
Thiobarbiturates, such as thiopental sodium
e938.3 Adv eff intraven Anesth Causing adverse effects; intravenous anesthetics, Ketamine, Methohexital [methohexitone],  
Thiobarbiturates, such as thiopental sodium
e938.4 Adv eff gen Anes nec/nos ausing adverse effects; other and unspecified general anesthetics
e938.4 Adv eff gen Anes nec/nos ausing adverse effects; other and unspecified general anesthetics
E938.5 Adv Eff Topic/Infil Anes Causing adverse effects; surface and infiltration anesthetics, Cocaine, Lidocaine [lignocaine], Procaine, 
Tetracaine
E938.5 Adv Eff Topic/Infil Anes Causing adverse effects; surface and infiltration anesthetics, Cocaine, Lidocaine [lignocaine], Procaine, 
Tetracaine
e938.6 Adv eff nerve-Block Anes Causing adverse effects; peripheral nerve- and plexus-blocking anesthetics
e938.7 Adv eff Spinal Anesthet Causing adverse effects; spinal anesthetics
e938.7 Adv eff Spinal Anesthet Causing adverse effects; spinal anesthetics
e939.0 Adv eff Antidepressants Causing adverse effects; antidepressants, Amitriptyline, Imipramine, Monoamine oxidase [MAO] inhibitors
e939.0 Adv eff Antidepressants Causing adverse effects; antidepressants, Amitriptyline, Imipramine, Monoamine oxidase [MAO] inhibitors
e939.1 Adv eff Phenothiaz Tranq Causing adverse effects; phenothiazine-based tranquilizers, Chlorpromazine, Fluphenazine, Phenothiazine, 
Prochlorperazine, Promazine
e939.1 Adv eff Phenothiaz Tranq Causing adverse effects; phenothiazine-based tranquilizers, Chlorpromazine, Fluphenazine, Phenothiazine, 
Prochlorperazine, Promazine
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e939.2 Adv eff Butyrophen Tranq Causing adverse effects; butyrophenone-based tranquilizers, Haloperidol, Spiperone, Trifluperidol
e939.2 Adv eff Butyrophen Tranq Causing adverse effects; butyrophenone-based tranquilizers, Haloperidol, Spiperone, Trifluperidol
e939.3 Adv eff Antipsychotc nec Causing adverse effects; other antipsychotics, neuroleptics, and major tranquilizers
e939.3 Adv eff Antipsychotc nec Causing adverse effects; other antipsychotics, neuroleptics, and major tranquilizers
e939.4 Adv eff Benzodiaz Tranq Causing adverse effects; benzodiazepine-based tranquilizers, Chlordiazepoxide, Diazepam, Flurazepam, 
Lorazepam, Medazepam, nitrazepam
e939.4 Adv eff Benzodiaz Tranq Causing adverse effects; benzodiazepine-based tranquilizers, Chlordiazepoxide, Diazepam, Flurazepam, 
Lorazepam, Medazepam, nitrazepam
e939.5 Adv eff Tranquilizer nec Causing adverse effects; other tranquilizers, Hydroxyzine, Meprobamate
e939.5 Adv eff Tranquilizer nec Causing adverse effects; other tranquilizers, Hydroxyzine, Meprobamate
e939.7 Adv eff Psychostimulants Causing adverse effects; psychostimulants, Amphetamine, Caffeine
e939.8 Adv eff Psychotropic nec Causing adverse effects; other psychotropic agents
e939.8 Adv eff Psychotropic nec Causing adverse effects; other psychotropic agents
e939.9 Adv eff Psychotropic nos Causing adverse effects; unspecified psychotropic agent
e939.9 Adv eff Psychotropic nos Causing adverse effects; unspecified psychotropic agent
e940.1 Adv eff Opiat Antagonist Causing adverse effects; opiate antagonists, Levallorphan, Nalorphine, Naloxone
e940.1 Adv eff Opiat Antagonist Causing adverse effects; opiate antagonists, Levallorphan, Nalorphine, Naloxone
e941.0 Adv eff Cholinergics Causing adverse effects; parasympathomimetics [cholinergics], Acetylcholine, Pilocarpine,  
Anticholinesterase: organophosphorus, reversible
e941.0 Adv eff Cholinergics Causing adverse effects; parasympathomimetics [cholinergics], Acetylcholine, Pilocarpine,  
Anticholinesterase: organophosphorus, reversible
e941.1 Adv eff Parasympatholytc Causing adverse effects; parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics,  
Atropine, Homatropine, Hyoscine [scopolamine], Quaternary ammonium derivatives
e941.1 Adv eff Parasympatholytc Causing adverse effects; parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics,  
Atropine, Homatropine, Hyoscine [scopolamine], Quaternary ammonium derivatives
e941.2 Adv eff Sympathomimetics Causing adverse effects; sympathomimetics [adrenergics], Epinephrine [adrenalin],  
Levarterenol [noradrenalin]
e941.2 Adv eff Sympathomimetics Causing adverse effects; sympathomimetics [adrenergics], Epinephrine [adrenalin],  
Levarterenol [noradrenalin]
e941.3 Adv eff Sympatholytics Causing adverse effects; sympatholytics [antiadrenergics], Phenoxybenzamine, Tolazoline hydrochloride
e941.3 Adv eff Sympatholytics Causing adverse effects; sympatholytics [antiadrenergics], Phenoxybenzamine, Tolazoline hydrochloride
e941.9 Adv eff Autonom Agnt nos Causing adverse effects; unspecified drug primarily affecting the autonomic nervous system
e942.0 Adv eff Card rhyth regul Causing adverse effects; cardiac rhythm regulators, Practolol, Procainamide, Propranolol, Quinidine
e942.0 Adv eff Card rhyth regul Causing adverse effects; cardiac rhythm regulators, Practolol, Procainamide, Propranolol, Quinidine
e942.1 Adv eff Cardiotonics Causing adverse effects; cardiotonic glycosides and drugs of similar action, Digitalis glycosides, Digoxin, 
Strophanthins
e942.1 Adv eff Cardiotonics Causing adverse effects; cardiotonic glycosides and drugs of similar action, Digitalis glycosides, Digoxin, 
Strophanthins
e942.2 Adv eff Antilipemics Causing adverse effects; antilipemic and antiarteriosclerotic drugs, Cholestyramine, Clofibrate
e942.2 Adv eff Antilipemics Causing adverse effects; antilipemic and antiarteriosclerotic drugs, Cholestyramine, Clofibrate
e942.4 Adv eff Coronary Vasodil Causing adverse effects; coronary vasodilators, Dipyridamole, Nitrates [nitroglycerin], Nitrites, Prenylamine
e942.4 Adv eff Coronary Vasodil Causing adverse effects; coronary vasodilators, Dipyridamole, Nitrates [nitroglycerin], Nitrites, Prenylamine
e942.5 Adv eff Vasodilators nec Causing adverse effects; other vasodilators, Cyclandelate, Diazoxide, Hydralazine, Papaverine
e942.5 Adv eff Vasodilators nec Causing adverse effects; other vasodilators, Cyclandelate, Diazoxide, Hydralazine, Papaverine
e942.6 Adv eff Antihyperten Agt Causing adverse effects; other antihypertensive agents, Clonidine, Guanethidine, Rauwolfia alkaloids,  
reserpine
e942.6 Adv eff Antihyperten Agt Causing adverse effects; other antihypertensive agents, Clonidine, Guanethidine, Rauwolfia alkaloids,  
reserpine
e942.9 Adv eff Cardiovasc nec Causing adverse effects; other and unspecified agents primarily affecting the cardiovascular system
e942.9 Adv eff Cardiovasc nec Causing adverse effects; other and unspecified agents primarily affecting the cardiovascular system
e943.0 Adv eff Antacids Causing adverse effects; antacids and antigastric secretion drugs, Aluminum hydroxide, Magnesium trisilicate
e943.0 Adv eff Antacids Causing adverse effects; antacids and antigastric secretion drugs, Aluminum hydroxide, Magnesium trisilicate
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e943.1 Adv eff irrit Cathartic Causing adverse effects; irritant cathartics, Bisacodyl, Castor oil, Phenolphthalein
e943.1 Adv eff irrit Cathartic Causing adverse effects; irritant cathartics, Bisacodyl, Castor oil, Phenolphthalein
e943.2 Adv eff emoll Cathartics Causing adverse effects; emollient cathartics, Sodium dioctyl sulfosuccinate
e943.2 Adv eff emoll Cathartics Causing adverse effects; emollient cathartics, Sodium dioctyl sulfosuccinate
e943.3 Adv eff Cathartics nec Causing adverse effects; other cathartics, including intestinal atonia drugs, Magnesium sulfate
e943.3 Adv eff Cathartics nec Causing adverse effects ; other cathartics, including intestinal atonia drugs, Magnesium sulfate
e943.5 Adv eff Antidiarrhea Agt Causing adverse effects; antidiarrheal drugs, Bismuth subcarbonate, Kaolin, Pectin
e943.5 Adv eff Antidiarrhea Agt Causing adverse effects; antidiarrheal drugs, Bismuth subcarbonate, Kaolin, Pectin
e943.8 Adv eff gi Agent nec Causing adverse effects; other specified agents primarily affecting the gastrointestinal system
e943.8 Adv eff gi Agent nec Causing adverse effects; other specified agents primarily affecting the gastrointestinal system
e944.1 Adv eff Purine Diuretics Causing adverse effects; purine derivative diuretics, Theobromine, Theophylline
e944.1 Adv eff Purine Diuretics Causing adverse effects; purine derivative diuretics, Theobromine, Theophylline
e944.2 Adv eff Acetazolamide Causing adverse effects; carbonic acid anhydrase inhibitors, Acetazolamide
e944.2 Adv eff Acetazolamide Causing adverse effects; carbonic acid anhydrase inhibitors, Acetazolamide
e944.3 Adv eff Saluretics Causing adverse effects; saluretics, Benzothiadiazides, Chlorothiazide group
e944.3 Adv eff Saluretics Causing adverse effects; saluretics, Benzothiadiazides, Chlorothiazide group
e944.4 Adv eff Diuretics nec Causing adverse effects; other diuretics, Ethacrynic acid, Furosemide
e944.4 Adv eff Diuretics nec Causing adverse effects; other diuretics, Ethacrynic acid, Furosemide
e944.5 Adv eff electrolyte Agnt Causing adverse effects; electrolytic, caloric, and water-balance agents
e944.5 Adv eff electrolyte Agnt Causing adverse effects; electrolytic, caloric, and water-balance agents
e944.7 Adv eff Uric Acid Metab Causing adverse effects; uric acid metabolism drugs, Phenoquin, Probenecid
e944.7 Adv eff Uric Acid Metab Causing adverse effects; uric acid metabolism drugs, Phenoquin, Probenecid
e945.1 Adv eff Smooth Musc relx Causing adverse effects; smooth muscle relaxants, Adiphenine, Metaproterenol [orciprenaline]
e945.1 Adv eff Smooth Musc relx Causing adverse effects; smooth muscle relaxants, Adiphenine, Metaproterenol [orciprenaline]
e945.2 Adv eff Skelet Musc relx Causing adverse effects; skeletal muscle relaxants, Alcuronium chloride, Suxamethonium chloride
e945.2 Adv eff Skelet Musc relx Causing adverse effects; skeletal muscle relaxants, Alcuronium chloride, Suxamethonium chloride
e945.3 Adv eff Musc Agt nec/nos Causing adverse effects; other and unspecified drugs acting on muscles
e945.4 Adv eff Antitussives Causing adverse effects; antitussives, Dextromethorphan, Pipazethate hydrochloride
e945.5 Adv eff expectorants Causing adverse effects; expectorants, Acetylcysteine, Cocillana, Terpin hydrate
e945.7 Adv eff Antiasthmatics Causing adverse effects; antiasthmatics, Aminophylline [theophylline ethylenediamine]
e945.7 Adv eff Antiasthmatics Causing adverse effects; antiasthmatics, Aminophylline [theophylline ethylenediamine]
e945.8 Adv eff resp Drg nec/nos Causing adverse effects; other and unspecified respiratory drugs
e946.0 Adv eff Loc Anti-infectv Causing adverse effects; local anti-infectives and anti-inflammatory drugs
e946.0 Adv eff Loc Anti-infectv Causing adverse effects; local anti-infectives and anti-inflammatory drugs
e946.1 Adv eff Antipruritics Causing adverse effects; antipruritics
e946.3 Adv eff emollient/Demulc Causing adverse effects; emollients, demulcents, and protectants
e946.5 Adv eff eye Anti-inf/Drg Causing adverse effects; eye anti-infectives and other eye drugs, Idoxuridine
e946.5 Adv eff eye Anti-inf/Drg Causing adverse effects; eye anti-infectives and other eye drugs, Idoxuridine
e946.6 Adv eff ent Anti-inf/Drg Causing adverse effects; anti-infectives and other drugs and preparations for ear, nose, and throat
e947.8 Adv eff Medicinal nec Causing adverse effects; other drugs and medicinal substances, Contrast media used for diagnostic x-ray 
procedures, Diagnostic agents and kits
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e947.8 Adv eff Medicinal nec Causing adverse effects; other drugs and medicinal substances, Contrast media used for diagnostic x-ray 
procedures, Diagnostic agents and kits
e947.9 Adv eff Medicinal nos Causing adverse effects; unspecified drug or medicinal substance
e947.9 Adv eff Medicinal nos Causing adverse effects; unspecified drug or medicinal substance
e948.0 Adv eff Bcg Vaccine Causing adverse effects; BCG vaccine
e948.8 Adv eff Bact Vac nec/nos Causing adverse effects; other and unspecified bacterial vaccines
e949.6 Adv eff Viral Vacc nec Causing adverse effects; other and unspecified viral and rickettsial vaccines, Mumps vaccine
e949.9 Adv eff Biologic nec/nos Causing adverse effects; other and unspecified vaccines and biological substances